{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:44:26Z","timestamp":1777866266291,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013120","name":"European Medicines Agency","doi-asserted-by":"publisher","award":["EMA\/2018\/23\/PE"],"award-info":[{"award-number":["EMA\/2018\/23\/PE"]}],"id":[{"id":"10.13039\/501100013120","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.vaccine.2023.12.065","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T08:27:13Z","timestamp":1704356833000},"page":"556-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions \u2013 A cross-sectional study in six EU member states"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9376-7574","authenticated-orcid":false,"given":"Caroline","family":"Buhl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8142-9807","authenticated-orcid":false,"given":"Ramune","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Birna","family":"Almarsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0482-5563","authenticated-orcid":false,"given":"Shahab","family":"Abtahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9713-4407","authenticated-orcid":false,"given":"Armin","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Deligianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foteini","family":"Dermiki-Gkana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Kontogiorgis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2293-1609","authenticated-orcid":false,"given":"Chara","family":"Oikonomou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirdza","family":"Kursite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elita","family":"Poplavska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Hegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marloes","family":"van der Goot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Bar\u00e3o","family":"Sousa Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Ribeiro-Vaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Marta","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitja","family":"Kos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan\u010da \u010cebron","family":"Lipovec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"van Vliet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa Leonardo","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2023.12.065_b0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41541-022-00569-8","article-title":"Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination","volume":"7","author":"Buoninfante","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2023.12.065_b0010","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211048815","article-title":"COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): a systematic review and post hoc analysis","volume":"27","author":"Hafeez","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.vaccine.2023.12.065_b0015","unstructured":"EMA. EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-raises-awareness-clinical-care-recommendations-manage-suspected-thrombosis-thrombocytopenia."},{"key":"10.1016\/j.vaccine.2023.12.065_b0020","unstructured":"EMA. Vaxzevria - Procedural steps taken and scientific information after the authorisation. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/procedural-steps-after\/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-procedural-steps-taken-scientific-information_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0025","unstructured":"EMA. DHPC - COVID-19 Vaccine AstraZeneca: Risk of thrombocytopenia and coagulation disorders. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/dhpc\/direct-healthcare-professional-communication-dhpc-vaxzevria-previously-covid-19-vaccine-astrazeneca_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0030","unstructured":"EMA. DHPC - VAXZEVRIA\/COVID-19 Vaccine AstraZeneca: link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/dhpc\/direct-healthcare-professional-communication-dhpc-vaxzevria-previously-COVID-19-vaccine-astrazeneca_en-0.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0035","unstructured":"EMA. DHPC - VAXZEVRIA\/COVID-19 Vaccine AstraZeneca: Risk of thrombosis in combination with thrombocytopenia \u2013 Updated information. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/dhpc\/direct-healthcare-professional-communication-dhpc-vaxzevria\/COVID-19-vaccine-astrazeneca-risk-thrombosis-combination-thrombocytopenia-updated-information_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0040","unstructured":"EMA. COVID-19 vaccine safety update VAXZEVRIA AstraZeneca AB - 29 March 2021. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/COVID-19-vaccine-safety-update\/COVID-19-vaccine-safety-update-vaxzevria-previously-COVID-19-vaccine-astrazeneca-29-march-2021_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0045","unstructured":"EMA. COVID-19 vaccine safety update VAXZEVRIA AstraZeneca AB - 11 May 2021. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/COVID-19-vaccine-safety-update\/COVID-19-vaccine-safety-update-vaxzevria-previously-COVID-19-vaccine-astrazeneca-11-may-2021_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0050","unstructured":"EMA. COVID-19 vaccine safety update VAXZEVRIA AstraZeneca AB - 21 May 2021. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/COVID-19-vaccine-safety-update\/COVID-19-vaccine-safety-update-vaxzevria-previously-COVID-19-vaccine-astrazeneca-21-may-2021_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0055","unstructured":"EMA. COVID-19 vaccine safety update VAXZEVRIA AstraZeneca AB - 18 June 2021. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/COVID-19-vaccine-safety-update\/COVID-19-vaccine-safety-update-vaxzevria-previously-COVID-19-vaccine-astrazeneca-18-june-2021_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0060","unstructured":"EMA. COVID-19 vaccine safety update VAXZEVRIA AstraZeneca AB - 14 July 2021. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/COVID-19-vaccine-safety-update\/COVID-19-vaccine-safety-update-vaxzevria-previously-COVID-19-vaccine-astrazeneca-14-july-2021_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0065","unstructured":"EMA. COVID-19 vaccine safety update VAXZEVRIA AstraZeneca AB - 8 September 2021. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/COVID-19-vaccine-safety-update\/COVID-19-vaccine-safety-update-vaxzevria-previously-COVID-19-vaccine-astrazeneca-8-september-2021_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0070","unstructured":"EMA. JCOVDEN - Procedural steps taken and scientific information after the authorisation. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/procedural-steps-after\/COVID-19-vaccine-janssen-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0075","unstructured":"EMA. DHPC - COVID-19 Vaccine Janssen: link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jun 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/dhpc\/direct-healthcare-professional-communication-dhpc-covid-19-vaccine-janssen-link-between-vaccine_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0080","unstructured":"EMA. DHPC - COVID-19 Vaccine Janssen: Contraindication in individuals with previous capillary leak syndrome and update on thrombosis with thrombocytopenia syndrome. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jun 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/dhpc\/direct-healthcare-professional-communication-dhpc-covid-19-vaccine-janssen-contraindication_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0085","unstructured":"EMA. COVID-19 vaccine safety update COVID-19 VACCINE JANSSEN Janssen-Cilag International NV - 14 April 2021. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/COVID-19-vaccine-safety-update\/COVID-19-vaccine-safety-update-COVID-19-vaccine-janssen-14-april-2021_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0090","unstructured":"EMA. COVID-19 vaccine safety update COVID-19 VACCINE JANSSEN Janssen-Cilag International NV - 11 May 2021. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/COVID-19-vaccine-safety-update\/COVID-19-vaccine-safety-update-COVID-19-vaccine-janssen-11-may-2021_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0095","unstructured":"EMA. COVID-19 vaccine safety update COVID-19 VACCINE JANSSEN Janssen-Cilag International NV - 18 June 2021. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/COVID-19-vaccine-safety-update\/COVID-19-vaccine-safety-update-COVID-19-vaccine-janssen-18-june-2021_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0100","unstructured":"EMA. COVID-19 vaccine safety update COVID-19 VACCINE JANSSEN Janssen-Cilag International NV - 14 July 2021. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/COVID-19-vaccine-safety-update\/COVID-19-vaccine-safety-update-COVID-19-vaccine-janssen-14-july-2021_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0105","unstructured":"EMA. COVID-19 vaccine safety update COVID-19 VACCINE JANSSEN Janssen-Cilag International NV - 6 October 2021. Amsterdam: European Medicines Agency; 2021 [accessed 2023 Jul 14]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/COVID-19-vaccine-safety-update\/COVID-19-vaccine-safety-update-COVID-19-vaccine-janssen-6-october-2021_en.pdf."},{"key":"10.1016\/j.vaccine.2023.12.065_b0110","unstructured":"EU PE&PV research network (2013). Impact of EU label changes and regulatory communication on SARS-CoV-2 adenovirus vector vaccines in context of thrombosis with thrombocytopenia syndrome (TTS): risk awareness and adherence (RiskAware TTS) EU PAS Register No: EUPAS 44970."},{"issue":"1","key":"10.1016\/j.vaccine.2023.12.065_b0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.vaccine.2022.11.035","article-title":"Persistent drop in confidence following US recommended pause of Ad26.COV2.S vaccine administration","volume":"41","author":"Rader","year":"2023","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2023.12.065_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274443","article-title":"Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen\/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population","volume":"17","author":"Salmon","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.12.065_b0125","unstructured":"ECDC. COVID-19 vaccine tracker. Stockholm: European Centre for Disease Prevention and Control; 2023 [accessed 2023 Mar 03] Available from: https:\/\/vaccinetracker.ecdc.europa.eu\/public\/extensions\/COVID-19\/vaccine-tracker.html#uptake-tab."},{"key":"10.1016\/j.vaccine.2023.12.065_b0130","series-title":"Types, sources, and claims of COVID-19 misinformation","author":"Brennen","year":"2020"},{"issue":"8","key":"10.1016\/j.vaccine.2023.12.065_b0135","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/10810730.2022.2136307","article-title":"Communication is not a virus: COVID-19 vaccine-critical activity on Facebook and implications for the 'Infodemic' concept","volume":"27","author":"Harper","year":"2022","journal-title":"J Health Commun"},{"issue":"9","key":"10.1016\/j.vaccine.2023.12.065_b0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-051352","article-title":"Negative consequences of failing to communicate uncertainties during a pandemic: an online randomised controlled trial on COVID-19 vaccines","volume":"12","author":"Batteux","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2023.12.065_b0145","article-title":"Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study","volume":"373","author":"Potteg\u00e5rd","year":"2021","journal-title":"BMJ"},{"issue":"29","key":"10.1016\/j.vaccine.2023.12.065_b0150","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024597118","article-title":"Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust","volume":"118","author":"Petersen","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2023.12.065_b0155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12889-017-4189-8","article-title":"The impact of non-response bias due to sampling in public health studies: a comparison of voluntary versus mandatory recruitment in a Dutch national survey on adolescent health","volume":"17","author":"Cheung","year":"2017","journal-title":"BMC Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23015116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23015116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:20:02Z","timestamp":1777537202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23015116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0264410X23015116"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.12.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions \u2013 A cross-sectional study in six EU member states","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.12.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}